# OnCo record werewolf-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/werewolf-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "werewolf-therapeutics" ;
  schema:name "Werewolf Therapeutics"@en ;
  schema:description "Werewolf makes conditionally activated cytokines (immune signalling proteins such as interleukin-2 and interleukin-12) that are switched on inside tumours. After selling a partnered programme to Jazz, the company agreed in August 2026 to merge with a pain-drug developer, which would end its independent cancer work."@en ;
  schema:url <https://onco.cc/companies/werewolf-therapeutics/>, <https://werewolftx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://werewolftx.com/>, <https://www.sec.gov/Archives/edgar/data/1785530/000178553026000018/a06302026ex991.htm>, <https://www.sec.gov/Archives/edgar/data/1785530/000119312526360059/d102535dex991.htm> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/cytokine-therapy/> ;
  onco:trials <https://onco.cc/trials/nct06939283/> .